FRT vs VNRX · rev $1.28B vs rev $1.4M
FRT (FRT) versus Volitionrx Ltd (VNRX) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
FRT currently screens at market cap $0. VNRX currently screens at market cap $15.9M.
Not investment advice. Open the FRT and VNRX stock pages for the full models.
Not investment advice.